A political 'bomb' over drug prices could threaten NAFTA 2.0
Source: Associated Press
A political bomb over drug prices could threaten NAFTA 2.0
By PAUL WISEMAN
February 12, 2019
WASHINGTON (AP) The clash over free trade in North America has long been fought over familiar issues: Low-paid Mexican workers. U.S. factories that move jobs south of the border. Canadas high taxes on imported milk and cheese.
But as Democrats in Congress consider whether to back a revamped regional trade pact being pushed by President Donald Trump, theyre zeroing in on a new point of conflict: Drug prices. They contend that the new pact would force Americans to pay more for prescription drugs, and their argument has dimmed the outlook for one of Trumps signature causes.
The presidents proposed replacement for the 25-year-old North American Free Trade Agreement is meant to win over Democrats by incentivizing factories to hire and expand in the United States. Yet the pact would also give pharmaceutical companies 10 years protection from cheaper competition in a category of ultra-expensive drugs called biologics, which are made from living cells.
Shielded from competition, critics warn, the drug companies could charge exorbitant prices for biologics.
This is an outrageous giveaway to Big Pharma, Rep. Rosa DeLauro, a Connecticut Democrat, said in an interview. The government guarantees at least 10 years of market exclusivity for biologic medicine. Its a monopoly. Its bad policy.
-snip-
Read more:
https://apnews.com/52fd2fe15baf481eac7cfde5d9dbf85d